Results 161 to 170 of about 1,433,262 (317)

Marked Long‐Term Improvement in Lung Function in Melanoma Differentiation–Associated Protein 5 Antibody–Positive Dermatomyositis Patients: Experience of a Single‐Center Longitudinal Cohort in North America

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah, Sangmee S. Bae, Tiffany De Leon, Yuna Lee, Rong Guo, David Elashoff, Jennifer Wang, Ani Shahbazian, Christina Charles‐Schoeman   +8 more
wiley   +1 more source

Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case Report. [PDF]

Pharmacol Res Perspect
Uno T, Nakakura I, Ikeda A, Hosoda A, Mukai Y, Yamanishi K, Ohara N, Imanishi K, Une Y, Yokoyama S, Hosomi K.   +10 more
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

INTRAVENOUS GELATIN

Annals of Surgery, 1943
A, Brunschwig, N, Corbin, C D, Johnston
openaire   +3 more sources

Medication Safety in Intravenous Therapy: Compatibility of Etoposide with Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration

Drug Design, Development and Therapy
Haiwen Ding,1– 3 Tong Tong,1– 3 Sheng Liu,1– 3 Liqin Tang,1– 3 Zhaolin Chen1– 3 1Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People’s ...
Ding H, Tong T, Liu S, Tang L, Chen Z
doaj  

Systematic review of the evidence of cardiac dysfunction and intravenous fluid use among children with severe acute malnutrition and severe dehydration. [PDF]

BMJ Paediatr Open
Narra R, Alberti K, Ciglenecki I, Allen BGS, de Polnay K, Tickell KD.   +5 more
europepmc   +1 more source

Effect of intravenous iron sucrose on hemoglobin level, when administered in a standard dose, to anemic pregnant women in rural Northern India

Journal of Family Medicine and Primary Care, 2019
Sakiyeva Kanshaiym, Ibrahim A Abdelazim, Tatyana Starchenko, Gulmira Mukhambetalyeva   +3 more
doaj   +1 more source

Transitioning From Oral to Intravenous Treprostinil in Pulmonary Arterial Hypertension: A Case Report. [PDF]

Clin Case Rep
Cummings AM, Konkol SB, Mihalek AD, Roth ME.   +3 more
europepmc   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns, Samuel D. Searle, Alexandra Legge   +2 more
wiley   +1 more source

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system. [PDF]

PLoS One
Ge D, Wu L, Yang J, Sun J, Wang J, Wang J, Song H, Wei R, Xu Z, Zhao B, Sun R, Wang Y.   +11 more
europepmc   +1 more source